Latest News & Features

Reset all filters
Article Type
Channels & Sectors
Geography
Company

Refine Search
Americas
The Patent Trial and Appeal Board rejected the Saint Regis Mohawk Tribe’s attempt to dismiss inter partes reviews related to dry-eye treatment Restasis late last week.   26 February 2018
Americas
Japan-based Takeda Pharmaceuticals has entered into a global strategic collaboration with Wave Life Sciences.   23 February 2018
Biotechnology
The EU General Court has crushed a company’s attempt to protect the Gala Schnico apple variety, today affirming a decision of the Community Plant Variety Office.   23 February 2018
Big Pharma
Johnson & Johnson has revealed plans to strengthen its medical device capabilities with the acquisition of French medical technology company Orthotaxy.   22 February 2018
Americas
Forming licensing agreements with other pharmaceutical companies is an important part of Pieris’s strategy, according to Ahmed Mousa, vice president of licensing, IP and legal affairs at the clinical-stage company.   22 February 2018
Asia
More than £500 million worth of life sciences and healthcare agreements were signed between the UK and China during the UK Prime Minister’s visit to China earlier this month.   21 February 2018
Big Pharma
Infringement and plausibility were the biggest issues on the battleground in the UK Supreme Court’s hearing in a case dealing with second medical use patents, as Claire Phipps-Jones, Katie Cambrook and Rachel Mumby of Bristows report.   21 February 2018
Americas
Trade associations Pharmaceutical Research and Manufacturers of America and Biotechnology Innovation Organization have called for Malaysia to be placed on the US Trade Representative’s watch list in its “2018 Special 301 Report”.   20 February 2018
Americas
District Judge Leonard Stark has reversed the record $2.54 billion verdict against Gilead Sciences for patent infringement, instead finding the patent in question to be invalid.   19 February 2018
Americas
Switzerland-based Roche has revealed plans to acquire a healthcare technology company for $1.9 billion.   19 February 2018